Literature DB >> 35792929

Macular and peripapillary vessel density alterations in a large series of patients with systemic lupus erythematosus without ocular involvement.

Sevgi Subasi1, Kubra Demirci Kucuk2, Senar San3, Ayse Cefle3, Ecem Onder Tokuc2, Sibel Balci4, Ayten Yazici3.   

Abstract

PURPOSE: The aim of this study was to investigate changes in both macular and peripapillary retinal microcirculation in the subclinical period of systemic lupus erythematosus (SLE) patients and to assess the relationship of these changes with disease activity, damage index, renal involvement, and use of hydroxychloroquine (HCQ).
METHODS: Sixty eyes of 60 SLE patients and 60 age-matched, healthy controls were evaluated with optical coherence tomography angiography (OCTA). Vessel densities, structural parameters, and foveal avascular zone (FAZ) assesments were made.
RESULTS: There was no significant correlation between activity and damage index and all regions of both superficial (SCP-VD) and deep capillary plexus vessel densities (DCP-VD) in the SLE group. There were no significant difference between groups in terms of FAZ, structural parameters, and radial peripapillary capillary vessel densities (RPC-VD). The mean SCP-VD and DCP-VD of most regions showed a significant decrease in the SLE group, except for parafovea superior and parafovea temporal. The decrease in vessel density (VD) in the perifoveal regions of DCP-VD in SLE patients was remarkable. DCP-VD showed good specifity and sensitivity in detecting vascular changes in SLE patients with whole image area under the curve (AUC) = 0.671, p < 0.001, odds ratio (OR) = 0.909, p = 0.009, and perifovea AUC = 0.671, p < 0.001, OR = 0.918, p = 0.012. Similarly, the SCP-VD whole image AUC = 0.609, p = 0.037, and OR = 0.825, p = 0.018 and perifovea AUC = 0.608, p = 0.037, and OR = 0.918, p = 0.012. The DCP-VD of perifovea superior showed a diagnostic accuracy for discrimination between SLE patients with and without nephritis (AUC = 0.671, p = 0.016). The SCP-VD and cumulative dose of HCQ demonstrated significant negative correlation in the SLE group (whole image, r =  - 0.332, p = 0.010).
CONCLUSIONS: SLE patients without ocular involvement had vascular changes that were particularly evident in the DCP and primarily in the perifovea. The perifovea superior of DCP had diagnostic utility in patients with nephropathy.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Optical coherence tomography angiography; Systemic lupus erythematosus; Vessel density

Mesh:

Substances:

Year:  2022        PMID: 35792929     DOI: 10.1007/s00417-022-05742-2

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.535


  17 in total

1.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

2.  The spectrum of ocular involvement in systemic lupus erythematosus in a tertiary eye care center in Nepal.

Authors:  Ranju Sitaula; Dev Narayan Shah; Divya Singh
Journal:  Ocul Immunol Inflamm       Date:  2011-12       Impact factor: 3.070

Review 3.  Retinopathy in systemic lupus erythematosus: pathogenesis and approach to therapy.

Authors:  D Giorgi; F Pace; A Giorgi; L Bonomo; C B Gabrieli
Journal:  Hum Immunol       Date:  1999-08       Impact factor: 2.850

4.  Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity.

Authors:  R J Cook; D D Gladman; D Pericak; M B Urowitz
Journal:  J Rheumatol       Date:  2000-08       Impact factor: 4.666

5.  Systemic lupus erythematosus disease activity index 2000.

Authors:  Dafna D Gladman; Dominique Ibañez; Murray B Urowitz
Journal:  J Rheumatol       Date:  2002-02       Impact factor: 4.666

Review 6.  Ocular manifestations of systemic lupus erythematosus: a clinical review.

Authors:  V Peponis; V C Kyttaris; C Tyradellis; I Vergados; N M Sitaras
Journal:  Lupus       Date:  2006       Impact factor: 2.911

7.  Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).

Authors:  Michael F Marmor; Ulrich Kellner; Timothy Y Y Lai; Ronald B Melles; William F Mieler
Journal:  Ophthalmology       Date:  2016-03-16       Impact factor: 12.079

8.  Lupus retinopathy. Patterns, associations, and prognosis.

Authors:  F J Stafford-Brady; M B Urowitz; D D Gladman; M Easterbrook
Journal:  Arthritis Rheum       Date:  1988-09

9.  Ocular manifestations of systemic lupus erythematosus: a review of the literature.

Authors:  Neal V Palejwala; Harpreet S Walia; Steven Yeh
Journal:  Autoimmune Dis       Date:  2012-07-02

Review 10.  Optical Coherence Tomography Angiography in Retinal Diseases.

Authors:  K V Chalam; Kumar Sambhav
Journal:  J Ophthalmic Vis Res       Date:  2016 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.